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Abstract
Objective: To assess the outcomes of linkage to TB and HIV care and identify risk factors for poor referral outcomes.
Design: Cohort study of TB patients diagnosed at an urban hospital.
Methods: Linkage to care was determined by review of clinic files, national death register, and telephone contact, and
classified as linked to care, delayed linkage to care (.7 days for TB treatment, .30 days for HIV care), or failed linkage to
care. We performed log-binomial regression to identify patient and referral characteristics associated with poor referral
outcomes.
Results: Among 593 TB patients, 23% failed linkage to TB treatment and 30.3% of the 77.0% who linked to care arrived late.
Among 486 (86.9%) HIV-infected TB patients, 38.3% failed linkage to HIV care, and 32% of the 61.7% who linked to care
presented late. One in six HIV-infected patients failed linkage to both TB and HIV care. Only 20.2% of HIV-infected patients
were referred to a single clinic for integrated care. A referral letter was present in 90.3%, but only 23.7% included HIV status
and 18.8% CD4 cell count. Lack of education (RR 1.85) and low CD4 count (CD4#50 vs. .250cells/mm3; RR 1.66) were
associated with failed linkage to TB care. Risk factors for failed linkage to HIV care were antiretroviral-naı̈ve status (RR 1.29),
and absence of referral letter with HIV or CD4 cell count (RR1.23).
Conclusions: Linkage to TB/HIV care should be strengthened by communication of HIV and CD4 results, ART initiation
during hospitalization and TB/HIV integration at primary care.
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Introduction
South Africa is one of the 22 countries with a high tuberculosis
(TB) burden [1]. In 2009, almost half a million new cases of
tuberculosis were notified in South Africa, [2] corresponding to a
rate of 971 cases per 100,000 population. The burden of HIV-
associated tuberculosis in South Africa is enormous, with an
estimated 73% of TB cases being HIV-infected, and one in four of
all global HIV-associated TB cases occurring in South Africa [1].
Adherence to treatment for TB and HIV is an important
determinant of a favourable treatment outcome, and those who
default treatment, especially if soon after treatment initiation,
continue to be a source of infection and transmission within the
community [3,4]. Patients with drug resistant TB that default
therapy pose an even greater risk to the public [5,6]. It is estimated
that a person with smear-positive TB will infect 10–14 people per
year [7]. The risk of transmitting HIV is mainly related to the HIV
viral load and level of risk behaviour [8]. While treatment
interruption during the course of TB treatment and antiretroviral
treatment (ART) have been extensively studied [9–13], little is
known about the linkage to care after the initial diagnosis [14],
particularly among people diagnosed with HIV-associated TB at a
hospital facility [15,16]. Because the cost-effectiveness of diagnos-
tic interventions is in part determined by successful linkage to care
[17,18], the rate of linkage to care should be monitored and
evaluated along with other programmatic targets [18,19]. Cur-
rently, rates of and reasons for failure to link TB and HIV
diagnosis with care are not collected as part of routine monitoring
and evaluation in TB and ART programs, making evidence-based
decisions on how to improve linkage to care difficult [20].
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We aimed to determine the proportion of people who fail to link
to care for TB and HIV treatment following a TB diagnosis at an
inner city hospital in Johannesburg, South Africa, and assess risk
factors for delayed or failed linkage to TB and HIV care.
Methods
Ethics statement
Study approval was obtained from the Human Research Ethic
Committee of the University of Witwatersrand, Institutional
Review Board of the University of North Carolina, the City of
Johannesburg (CoJ) municipality and the Helen Joseph hospital. A
waiver of written informed consent was granted by the ethics
committees (retrospective review of existing medical records).
Verbal informed consent for use of information provided by
individuals contacted by phone was obtained from all individuals
and documented in writing on the informed consent form used. All
data was de-identified prior to analysis and analysed anonymously.
Setting and patient population
The TB focal point (TBFP) at the Helen Joseph public hospital
in Johannesburg, South Africa, provides routine TB diagnosis for
inpatients and some outpatients, TB education, and HIV
counselling, testing and staging for TB suspects and TB patients.
All activities are performed according to National TB guidelines
[21,22]. During the study period, the South African guidelines
recommended ART initiation as soon as the patient is stable and
completed at least two weeks of TB treatment if CD4 count is less
than 50 cells/mm or in the presence of other serious HIV
‘‘illnesses’’; at the end of the two-month intensive phase of TB
therapy if CD4 count is between 50 cells/mm and 200 cells/mm;
and after completion of TB therapy if CD4 count was above 200
cells/mm and there were no other HIV-related symptoms.
Patients are referred for continuation of TB treatment to the
most appropriate local primary health care clinic based on the
patient’s home or work address, and provided with TB medication
for 7 days. Patients on ART are provided with antiretroviral drugs
for 30 days and ART-naı̈ve HIV-infected patients are instructed to
present for HIV care and treatment within 30 days of referral.
National guidelines state that if possible, the patient should either
be transported to the clinic by health services, be accompanied by
a DOT supporter or social worker, or the local PHC clinic should
collect the patient. If this is not possible the hospital should follow
up directly with the clinic to confirm that the patient has arrived
[21,22]. Because the TBFP does not have the capacity to
accompany patients or to confirm arrival of all patients, a
standard South African TB Programme referral letter (‘‘pink’’)
form is given to the patient to deliver to the referral clinic. A copy
of this referral letter is sent directly to the clinic where the patient is
referred to, and a third copy is kept at the TBFP. The guidelines
further instruct that the pink referral form must be completed in
detail with all relevant information. [21,22] While the form
includes a field ‘‘other information’’, there is no dedicated space
for HIV status or CD4 count.
All adults (age 18 years or older) registered with active TB at the
TBFP with TB between October 1 and December 31, 2009 and
referred to a clinic within the CoJ health district were included in
the analysis.
Data collection
The TBFP routinely collects socio-demographic data, clinical
information, laboratory results related to TB and HIV care,
patient contact information and the name of the clinic(s) patients
are referred to for TB and HIV treatment.
For the study, data on the outcome of the referral process was
collected 3 months (median 192 days, range 161–231) after
referral from TBFP to ensure capture of late presenters (Figures 1
and 2). Referral clinics were visited to confirm patient arrival by
interviewing the TB nurse and reviewing the clinic TB register.
The patient TB file was reviewed to determine the exact date of
patient arrival, standard referral form for documentation of HIV
and CD4 cell count information, locate the pink form or any other
referral documents, and review documentation on HIV status,
care and treatment. For patients with HIV-associated TB,
TherapyEdgeTM an electronic database, used by several HIV
clinics in Johannesburg, was reviewed to establish linkage to HIV
care. CoJ clinics that did not use Therapy Edge-HIVTM were
visited. In total, study staff visited 98 clinics within CoJ.
When documentation of patient arrival at the referral clinic for
TB and HIV treatment was not found, the electronic South
Africa’s National Vital Registration system was consulted to verify
the alive or deceased status of the patient. Patients that were alive
or with unknown survival status were contacted telephonically
using a standardized script to enquire about TB and, if applicable,
HIV treatment. If patients reported they had presented for TB
and/or HIV treatment, the name of the clinic was recorded and
the clinic was visited to confirm attendance.
Data analysis
The primary outcome was time to arrival at the referral clinic,
categorized as (i) linked to care, (ii) delayed linkage to care (iii)
failed of linkage to care. Delayed linkage to care was defined as
presentation for TB treatment more than 7 days or presentation
for HIV care and treatment more than 30 days after hospital
discharge, corresponding to the 7 day supply of TB treatment, 30
day supply of antiretroviral drugs, or a 30 days period during
which the ART-naive patients were asked to present for HIV care.
Failed linkage to care included patients who self-reported not
being in care as well as patients who had no record of care and
could not be traced by phone, assuming they had not presented for
care. Initiation of care in people who could not be traced could not
be excluded. We therefore explored the potential of misclassifica-
tion in a sensitivity analysis in which all patients who could not be
traced were classified as having linked to care. Patients who died
within 7 days or 30 days of referral for TB or HIV care,
respectively, were classified as deceased during referral process.
Multiple log-binomial regression analysis was performed to
identify patient and referral characteristics independently associ-
ated with delayed and failed linkage to TB and HIV care,
respectively. Measures of association were expressed as relative
risks (RR) and their 95% confidence intervals (CI). Variables
associated with the outcome in bivariate analysis at p#0.20 were
considered in regression models. Data was analyzed using SAS 9.1




During the 3-month study period, 678 adults were registered
with active TB at the TBFP, of which 593 were referred to a CoJ
clinic and included in the analysis. Demographic and clinical
characteristics of patients referred to CoJ clinics did not differ from
the overall cohort (p.0.2). Median age was 35.9 years (IQR 30.6–
43.5), 50% were female, 82.6% were of South African nationality,
80% had an education level of grade 8 or higher, and 54.7% were
unemployed (Table 1). The majority (68.5%) had smear-negative
TB. Most patient (86.9%) were HIV-infected, 8.9% were HIV
Linkage to TB and HIV Care
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negative and 4.2% of patients had an unknown HIV status.
Median CD4 cell count at TB diagnosis was 78 cells/mm3 (IQR
30–178). At time of referral, only 21% of HIV-infected patients
were receiving ART.
Linkage to TB care
Overall, 137 (23%) patients failed to link to TB care and 456
(77%) presented to a clinic for continuation of TB care and
treatment (Table 2). Among the 456 who had linked to care, 126
(27.6%) had presented to a clinic other than the one they had been
referred to by TBFP staff. The median time to presentation was 5
days (IQR 2 -10) but 138 (30.3%) arrived late, after their 7 day
supply of TB drugs expired. Among the 415 patients who arrived
for TB care at a CoJ clinic, 375 (90.3%) had a clinic file that
contained a referral letter but this letter contained the HIV status
in only 23.7% of patients, and the CD4 cell count was
communicated in as few as 18.8% of HIV-infected TB patients.
Among the 137 (23%) patients classified as failure to link to TB
care, 6 (4.4%) had died within the first 7 days after TBFP referral,
38 (27.7%) self-reported they had never presented at a TB clinic
and 93 (67.9%) could not be traced.
Linkage to HIV care and treatment
Among the 515 patients with HIV-associated TB, 486 were
referred to a CoJ clinic and included in the analysis. Of the 486
patients, 186 (38.3%) failed to link to HIV care and 300 (61.7%)
presented for HIV care and treatment (Table 2). Among those that
linked to HIV care, 66 (22.0%) had presented to a clinic different
than the one they had been referred to by the TBFP staff. The
median time to presentation was 17 days (IQR 5–48), but 32%
presented late, more than 30 days after referral by the TBFP.
Among the 186 patients classified as failed linkage to care, 10
(5.4%) had died within the first 30 days of referral, 82 (44.1%)
admitted they had never presented at a HIV clinic, and 94 (50.5%)
could not be traced.
The majority of patients (79.8%) had been referred to two
separate clinics, one for TB treatment and one for HIV care and
treatment. Among ART-naı̈ve patients, 12% were inappropriately
referred to a clinic not accredited for ART initiation.
Figure 1. Flow chart representing the assessment of linkage to TB treatment. This flow chart details the data collection and verification
process used to determine the outcome of referral of 593 TB patients for continuation of TB treatment at primary care level. Data was collected three
months (median 192 days) after referral to ensure capture of data on individuals who presented late after referral.
doi:10.1371/journal.pone.0049140.g001
Figure 2. Flow chart representing the assessment of linkage to HIV care and treatment. This flow chart details the data collection and
verification process used to determine the outcome of referral of 486 HIV co-infected patients with TB for continuation of HIV care and treatment.
Data was collected 3 months (median 192 days) after referral to ensure capture of data on individuals who presented late after referral.
doi:10.1371/journal.pone.0049140.g002
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Correlation of linkage to TB and HIV care and treatment
(in patients with recorded arrival times)
Among patients with HIV-associated TB, exact dates of arrival
were available for 461 (91.5%) patients. One in six HIV-infected
TB patients (16.7%) failed to link to both HIV and TB care and
treatment, about half (55.5%) linked to both HIV and TB care and
treatment; one in five (22.3%) linked to TB treatment but failed to
link to HIV care, and few (5.4%) linked to HIV care and treatment
but failed to link to TB treatment. Patients who failed to link to
HIV care were also at increased risk of failure to link to TB care
(RR 1.59, 95% CI 1.42–1.76).
Factors associated with delayed or failed linkage to TB or
HIV care and treatment
In bivariate analysis, being a non-South African (RR 1.42; 95%
CI 1.04–1.92), lack of formal education (RR 2.06; 95% CI 1.36–
3.11), and low CD4 (#50 vs. .250 cells/mm3; RR 2.22; 95% CI
1.24–3.96) were associated with increased risk of failed linkage to
TB care (Table 3). Risk factors for delayed linkage to care were
being a non-South African (RR 1.38 95% CI 1.02–1.86), lack of
formal education (RR 2.02, 95% CI 1.38–2.96), being ART-naı̈ve
at referral (RR 1.67; 95% CI 1.07–2.60), and the absence of a
referral letter in the TB clinic file (RR 1.82, 95% CI 1.34–2.49). In
multivariate analysis, the lack of formal education (aRR 2.12 95%
CI 1.44–3.09) and absence of a discharge letter (aRR 1.47 95% CI
1.02–2.11) were independently associated with increased risk of
delayed linkage to TB care. Lack of formal education (aRR 1.85
95% CI 1.31–2.61) and low CD4 (#50 vs. .250cells/mm3; aRR
1.66 95% CI 1.07–2.64) were independently associated with
increased risk of failed linkage to TB care.
Factors associated with increased risk of poor outcome of HIV
referral in bivariate analysis were being ART-naı̈ve at referral (RR
1.53, 95% CI 1.01–2.31 for delayed linkage to HIV care; RR 2.69,
95% CI 1.74–4.16 for failed linkage to HIV care), and referral to
an inappropriate HIV clinic (RR 1.81, 95% CI 1.20–2.73 for
delayed and RR 1.84, 95% CI 1.52–2.23 for failed linkage to HIV
care) (Table 4). In addition, having a non-South African
nationality (RR 1.27, 95% CI 1.01–1.59) and lack of HIV status
and CD4 count information on the referral letter received at the
TB clinic increased the risk of failure to link to HIV care (RR 1.86,
95% CI 1.49–2.34). There were no clear trends in association
between CD4 cell count and delayed or failed linkage to HIV care.
In multivariate analysis, being ART-naı̈ve (RR1.29, 95% CI 1.10–
1.52) and absence of HIV status and CD4 count on the referral
letter (RR 1.23, 95% CI 1.10–1.38) independently increased the
risk of failed linkage to HIV care.
Sensitivity analysis
Despite intensive investigations, 15.7% of patients could not be
traced regarding linkage to TB care and 19.3% could not be
traced to obtain information on HIV care. In the primary analysis,
these patients were assumed not to have linked to care, which may
have overestimated the rate of failed linkage to care. A sensitivity
analysis in which all patients who could not be traced were
classified as having linked to care, gave similar results compared to
the main analysis. Being a non-South African (RR 1.30 95% CI
0.64–2.64), lack of formal education (RR 1.32 95% CI 0.61–2.88)
and low CD4 count (#50 vs. .250cells/mm3; RR 3.29 95% CI
0.42–25.97) resulted in a higher risk of failed linkage to TB care,
but the association was no longer statistically significant, possibly
due to the lower numbers of patients who failed to link to care in
this analysis. Regarding linkage to HIV care, being ART-naı̈ve at
referral (RR 5.47 95% CI 2.06–14.49) and referral to an
inappropriate HIV clinic (RR 1.93 95% CI 1.25–2.98) were
associated with failure to link to HIV care in the sensitivity
analysis; being a non-South African (RR 1.08 95% CI 0.69–1.70)
and lack of HIV status and CD4 count on the referral letter
received at the TB clinic (RR 0.94 95% CI 0.64–1.38) were no
longer associated with failing linkage to HIV care in the sensitivity
analysis.
Discussion
We observed inadequate referral outcomes despite the imple-
mentation of a TB focal point infrastructure with a strong
emphasis on integrated TB/HIV diagnosis. Almost one in four
(23%) of patients failing to link to TB treatment at a primary care
clinic, and 30% of those linking to care arrived after their 7 day
supply of drugs expired. Linkage to HIV care was even more
inadequate, with 38.3% of HIV-positive patients failing to present
themselves to HIV care. Among HIV-infected TB patients, only
55.5% achieved linkage to both TB and HIV care, and one in six
failed linkage to both TB and HIV care.
Table 1. Baseline demographics and clinical characteristics of
593 patients diagnosed with TB at the Helen Joseph Hospital
TB focal point.
Patient
characteristic N or median % or IQR
Gender (n, %) Male 295 50
Female 298 50
Age at TB-FP (years) Median (IQR) 35.9 30.6–43.5
#40 395 66.6
.40 198 33.4







Employment No 321 54.7
Yes 265 45.3
Education No education 30 5.1
,Grade 8 88 14.9
$Grade 8 471 80.0
HIV status HIV negative 53 8.9
HIV positive 515 86.9
On ART 108 21.0
Not on ART 407 79.0
Unknown status 25 4.2
CD4 cell count Median (IQR) 78 30–178
#50 cell/mm3 186 37.3
51–100 cell/mm3 101 20.3
101–250 cell/mm3 138 27.7
.250 cell/mm3 73 14.7
Time in Johannesburg was missing in 104 patients, employment status in 7
patients, education status in 4 patients for, and CD4 cell count results in 17
patients.
doi:10.1371/journal.pone.0049140.t001
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Our findings are in contrast to the observations by Edginton et
al [16] who observed that the introduction of a TB care centre at
another large hospital in Johannesburg, South Africa, improved
patient referral with 93% of TB patients achieving successful
referral to a clinic for continuation of TB treatment and nurses
reporting that patients arrived ‘‘well-informed and motivated to
continue treatment with referral documentation that were
accurate and complete’’ [16].
Most socio-demographic characteristics, including age, gender
and employment status, were not associated with poor outcomes of
the referral process. Lack of formal education resulted in a two-
fold risk of delayed and failed linkage to TB care, and being non-
South African increased the risk by about 40%. As observed
elsewhere, staff may not spend enough time on patient education
and may not be able to communicate in the patient’s native
language [16]. In a Ugandan study, not being aware that TB is
curable and not knowing the duration of anti-TB treatment was
associated with poor linkage to TB treatment in patients with
HIV-associated TB [23]. Foreign-born individuals and those who
lack formal education may find it especially challenging to
interpret information provided at referral and may be less
empowered to seek continuation of care.
High rates of losses to care between HIV diagnosis and HIV
care have been observed in many settings, highlighting the need
for robust referral systems and a better understanding of risk
factors [10–12,24–27]. In our cohort of patients with HIV-
associated TB, being ART-naive at time of referral was associated
with a 30% increased risk of failed linkage to HIV care, and
Table 2. Outcome of referral from Helen Joseph hospital TB focal point to City of Johannesburg clinic for continuation of TB
treatment (n = 593) and HIV care and treatment (n = 486).
Outcome of referral N % or IQR
Linkage to TB care Arrived at TB clinic 456 77.0
Arrived at original referral clinic 330 72.4
Arrived at other clinic within COJ 85 18.6
Arrival at TB clinic outside COJ 41 9.0
Failed to link to TB care 137 23
Patient confirms not attending any TB clinic 38 27.7
Died within 7 days of discharge 6 4.4
Loss to follow-up 93 67.9
Timing of linkage to TB care* Median, IQR (days) 5 2–10
Arrived on time (#7 days) 277 60.7
Arrived late (.7 days) 138 30.3
Arrived (exact date missing) 41 9.0
Referral information at TB clinic** Referral letter present in clinic file 375/415 90.3
Referral letter with HIV status 89/375 23.7
Among HIV positive, referral letter with CD4 count 68/361 18.8
No discharge letter received at clinic 40/415 9.6
Linkage to HIV care Arrival at HIV clinic 300 61.7
Arrived at original HIV referral clinic 230 76.7
Arrived at other HIV clinic within COJ 66 22.0
Arrival at HIV clinic outside COJ 4 1.3
Failed to arrive 186 38.3
Patient confirms not attending any HIV clinic 82 44.1
Loss to follow-up 94 50.5
Died within 30 days of referral 10 5.4
Timing of linkage to HIV care*** Median, IQR (days) 17 5–48
Arrived in time (#30 days) 191 63.7
Arrived late (.30 days) 96 32.0
Arrived (exact date missing) 13 4.3
Type of referral clinic Same TB and HIV referral site 98 20.2
Two different referral sites for HIV and TB 386 79.8
Appropriateness of referral HIV clinic Appropriate 426 87.7
Not appropriate* 60 12.3
*Among 456 patients who linked to TB care;
**Among 415 patients who linked to TB care at a COJ clinic;
***Among 300 HIV infected TB patients who linked to HIV care *Not appropriate = referral of an ART-naı̈ve patients to clinic where ART is not initiated; CoJ = City of
Johannesburg; IQR = interquartile range.
doi:10.1371/journal.pone.0049140.t002
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around a 40–50% increased risk for delayed linkage to HIV and
TB care, although the latter was not statistically significant. In
contrast to Basset et al [20], who found that patients with a CD4
cell count #100 cell/mm3 were twice as likely to be lost to care
before ART initiation, CD4 count was not a risk factor for failure
to link to HIV care in our population of HIV-infected TB patients.
The increased risk of failure to link to HIV care among TB
patients who are ART-naı̈ve at time of referral highlights a lost
opportunity for reducing early mortality among those with
advanced immunosuppression [28–30] and suggest that initiation
of ART during hospitalization, may not only improve survival but
also reduce the likelihood of failure of linkage to care at primary
care level.
The efforts towards an integrated TB/HIV approach at the
hospital TBFP resulted in a 95.8% HIV testing rate and 84% of
HIV-positive patients being evaluated by CD4 cell count.
Unfortunately, the information on HIV status reached the primary
care providers in only 23.7% of patients who linked to TB care,
and the results of CD4 cell count were available at primary care
level for only 18.8% of HIV-infected TB patients who linked to
TB care. Failure to communicate HIV-related information to the
health care worker, often because of confidentiality concerns,
negatively impacts on patient care, as demonstrated by a 23%
increased risk of failure to link to HIV care, and results in great
inefficiency and high costs of duplicating efforts at different levels
of the health care system. Our findings highlights the need to
communicate HIV status and CD4 count at time of referral and
suggest that national programs should consider revising the
standard referral document if this does not contain designed
entries for HIV-related information.
Integration of TB and HIV care at primary care level was poor,
with 80% of patients with HIV-associated TB being referred to
two separate clinics, one for TB and one for HIV care. The Pro-
TEST study in urban Zambia demonstrated that delivery of
integrated services, including a strong referral system reduces
patient costs and is financially feasible and inexpensive [17].
Our study had several strengths, including the assessment of
linkage to both TB and HIV care in a single cohort of patients,
and extending data collection from the conventional review of
registers or files at the referral clinic to review of an electronic HIV
database, national death register, and telephone contact with
patients who could not otherwise be traced [31–35]. The
observation that 28% of patients who linked to care choose to
go to a clinic other than the one they were referred to for
continuation of TB treatment demonstrates the importance of this
approach. Our study also had several limitations. First, even
though the sample size was large, some estimates were imprecise
due to small cell numbers in covariate strata. Second, despite
intensive investigations, exact dates of arrival were missing in up to
9% of patients, 15.7% of patients could not be traced regarding
linkage to TB care and 19.3% could not be traced to obtain
information on HIV care. In the analysis, these patients were
assumed not to have linked to care, which may have overestimated
the rate of failed linkage to care. The results of a sensitivity
analysis, in which these patients were classified as having linked to
care, however suggested that potential misclassification did not
substantially influence our conclusions.
Table 3. Factors associated with delayed or failed linkage to TB care in 593 patients referred from Helen Joseph hospital TB focal
point to City of Johannesburg (COJ) clinic for TB treatment.
Delayed linkage to care (.7 days) (n = 138) Failed linkage to care (n = 131#)
N Crude RR (95% CI) Adjusted RR (95% CI) N Crude RR (95% CI)
Adjusted RR (95%
CI)
Sex Female 73 Reference 63 Reference
Male 65 0.94 (0.71–1.23) 68 1.07 (0.81–1.42)
Age ,36 years 74 Reference 64 Reference
$36 years 64 0.92 (0.70–1.21) 67 1.04 (0.80–1.39)
Nationality South African 103 Reference Reference 97 Reference Reference
Other 35 1.38 (1.02–1.86) 1.39 (0.92–2.17) 34 1.42 (1.04–1.92) 1.18 (0.87–1.59)
Education $Grade 8 108 Reference Reference 100 Reference Reference
,Grade 8 18 0.97 (0.64–1.46) 0.95 (0.62–1.46) 20 1.09 (0.74–1.63) 1.06 (0.75–1.49)
No education 11 2.02 (1.38–2.96) 2.12 (1.44–3.13) 10 2.06 (1.36–3.11) 1.85 (1.31–2.61)
Unemployed No 66 Reference 53 Reference
Yes 71 0.96 (0.73–1.26) 75 1.16 (0.87–1.55)
ART status On ART 17 Reference Reference 22 Reference
ART-naive 110 1.67 (1.07–2.60) 1.39 (0.92–2.17) 91 1.22 (0.82–1.81)
CD4 count .250 cell/mm3 22 Reference Reference 10 Reference Reference
101–250 cell/mm3 27 0.72 (0.46–1.15) 0.80 (0.51–1.25) 27 1.27.(0.67–2.40) 1.16 (0.71–1.83)
51–100 cell/mm3 26 0.91 (0.36–1.43) 0.98 (0.65–1.49) 15 1.07 (0.53–2.17) 1.07 (0.62–1.83)
#50 cell/mm3 47 1.13 (0.76–1.67) 1.07 (0.75–1.53) 58 2.22 (1.24–3.96) 1.66 (1.07–2.64)
Discharge letter Yes 115 Reference Reference NA NA
No 23 1.82 (1.34–2.49) 1.47 (1.02–2.11)
RR = relative risk, CI = confidence interval; ART = antiretroviral treatment.
Patients who died within 7 days of referral are not included in delayed or failed linkage to care.
doi:10.1371/journal.pone.0049140.t003
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In conclusion, the proportion of patients that failed to link to TB
and HIV care was unacceptably high despite efforts to integrate
TB and HIV care and streamline referral for patients diagnosed
with TB at the hospital. The high rates of HIV co-infection and
the high degree of immunosuppression in the population highlight
the urgent need for strengthened linkages to and integration of
care. Factors associated with linkage to care were predominantly
health system related and could be improved through appropriate
interventions. Efforts to improve linkage to care could include
ART initiation during hospitalization to reduce the proportion of
TB patients who are ART-naı̈ve at time of referral; improving the
quality and content of patient education and adapting referral
information to the patient’s level of education to overcome failure
of linkage to care among those who lack formal education;
discussing referral clinic options with the patient instead of simply
assuming that the preferred clinic from the patient perspective is
the one closest to their home; referring patients to a single clinic
for integrated TB and HIV care; ensuring that ART-naı̈ve
patients are referred to a clinic that is accredited to initiate ART;
and changing the standard reference referral letter to ensure that
information on TB, HIV status and CD4 cell count is shared.
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